Stock 600572 ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang CONBA Pharmaceutical Co.,Ltd.

Equities

600572

CNE000001H86

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
4.91 CNY +0.61% Intraday chart for Zhejiang CONBA Pharmaceutical Co.,Ltd. -2.58% -2.77%
Apr. 19 Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 01 Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024. CI

Valuation

Fiscal Period: December 2019 2022 2023 2024 2025 2026
Capitalization 1 15,806 12,156 12,979 12,619 - -
Enterprise Value (EV) 1 15,806 12,156 12,979 12,619 12,619 12,619
P/E ratio -47.3 x 33.8 x 22 x 16 x 13.5 x 12 x
Yield - - 3.96% 2.85% 3.16% -
Capitalization / Revenue - - 1.93 x 1.63 x 1.4 x 1.27 x
EV / Revenue - - 1.93 x 1.63 x 1.4 x 1.27 x
EV / EBITDA - - 11.6 x 8.75 x 7.86 x 7.12 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - 1.84 x 1.67 x 1.55 x 1.29 x
Nbr of stocks (in thousands) 2,570,037 2,570,037 2,570,037 2,570,037 - -
Reference price 2 6.150 4.730 5.050 4.910 4.910 4.910
Announcement Date 4/28/20 4/11/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2022 2023 2024 2025 2026
Net sales 1 - - 6,733 7,756 9,015 9,918
EBITDA 1 - - 1,116 1,443 1,606 1,772
EBIT 1 - - 788.3 1,058 1,307 1,447
Operating Margin - - 11.71% 13.65% 14.5% 14.59%
Earnings before Tax (EBT) 1 - - 767.7 1,044 1,290 1,432
Net income 1 -345.6 358.1 591.6 782.4 927.4 1,062
Net margin - - 8.79% 10.09% 10.29% 10.71%
EPS 2 -0.1300 0.1400 0.2300 0.3067 0.3633 0.4100
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - 0.2000 0.1400 0.1550 -
Announcement Date 4/28/20 4/11/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 1,549 1,824 1,794 1,829 1,965
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income 107.1 - - - - -
Net margin - - - - - -
EPS 2 0.0420 -0.0100 0.0840 0.0700 0.0600 0.0300
Dividend per Share - - - - - -
Announcement Date 10/27/23 4/19/24 4/26/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - 8.45% 10.1% 11.6% 10.9%
ROA (Net income/ Total Assets) - - - 6.6% 7.3% -
Assets 1 - - - 11,855 12,705 -
Book Value Per Share 2 - - 2.740 2.940 3.180 3.810
Cash Flow per Share 2 - - 0.3500 0.3200 0.4400 0.5400
Capex 1 - - 113 676 676 -
Capex / Sales - - 1.68% 8.72% 7.5% -
Announcement Date 4/28/20 4/11/23 4/19/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang CONBA Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.91
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD. Stock Zhejiang CONBA Pharmaceutical Co.,Ltd.
-2.77% 1.74B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.37% 43.34B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.44% 21.96B
SANDOZ GROUP AG Stock Sandoz Group AG
+10.86% 14.09B
CIPLA LIMITED Stock Cipla Limited
+12.68% 13.64B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.36% 11.43B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.59% 6.86B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+8.46% 5.22B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600572 Stock
  4. Financials Zhejiang CONBA Pharmaceutical Co.,Ltd.